Howard J. Leonhardt Named Finalist for Orange County Business Journal Innovator of the Year

Lionheart Health founder recognized for advancing bioelectric medicine, multi-organ regeneration and healthspan technologies ORANGE COUNTY, Calif. — FOR IMMEDIATE RELEASE…
Howard and Team

Lionheart Health founder recognized for advancing bioelectric medicine, multi-organ regeneration and healthspan technologies

ORANGE COUNTY, Calif. — FOR IMMEDIATE RELEASE — Lionheart Health, Inc. announced that Howard J. Leonhardt, Executive Chairman and Co-CEO, has been named a finalist among 60 innovators being honored by the Orange County Business Journal in connection with its 12th Annual Innovator of the Year Awards.

The recognition celebrates Orange County innovators whose ideas, leadership and accomplishments are helping shape the future of business and technology throughout the region.

The Orange County Business Journal will honor this year’s innovators at its annual awards luncheon on Wednesday, October 7, 2026, at the Irvine Marriott.

Leonhardt’s recognition comes as Lionheart Health advances a growing portfolio of technologies spanning bioelectric medicine, regenerative medicine, multi-organ regeneration, muscle health and healthspan longevity.

Octopus™ Multi-Organ Regeneration System

At the forefront of Lionheart Health’s development pipeline is the Lionheart Octopus™ Multi-Organ Regeneration System, being developed in collaboration with the University of California, Irvine Capstone Engineering Program.

The Octopus platform is being designed as a next-generation, multi-channel bioelectric system capable of delivering precisely programmed stimulation protocols to multiple areas of the body.

The long-term vision is to develop an integrated platform for investigating bioelectric signaling and bioelectric enhanced biologics designed to support the repair and regeneration of multiple organs and tissues, in multi-modality combination with complementary regenerative technologies such as bioelectric enhanced peptides, exosomes, amniotic fluid, Wharton’s Jelly, stem cells, nanoflowers and stromal fraction.

The UCI Capstone Engineering collaboration is helping advance system engineering, electronics, controls, electrode interfaces and other components needed to develop this multi-organ platform.
Multi organ

Lionheart 240 Stimulator™ — Bioelectric Technology Already on the Market

While Lionheart advances its next generation of regenerative technologies, the company is also commercializing the Lionheart 240 Stimulator™, a programmable electrical stimulation platform manufactured in Orange County, California, by Mettler Electronics, with assistance from HTM Electronics of Brazil.

The Lionheart 240 is already on the market and being sold to clinics, with the platform capable of supporting up to 25 different stimulation programs and indications of use, subject to the applicable regulatory status and permitted claims for each application.

The platform allows Lionheart and participating clinics to deploy specialized stimulation programs across areas such as muscle conditioning, circulation, pain management and other wellness, rehabilitation and investigational regenerative-health applications.

Lionheart views the 240 platform as an important commercial foundation for its broader strategy of developing precisely programmed bioelectric signals for multiple aspects of human health.
Top health practitioner

BodStim™ EMS — Building Muscle and Studying Healthspan

Lionheart is also advancing the BodStim™ whole-body EMS exercise suit, which combines electrical muscle stimulation with exercise.

The underlying EMS technology is FDA cleared for applications that augment the benefits of exercise and support muscle conditioning, including helping users build muscle more efficiently when used as intended with exercise.

Lionheart has additionally developed specialized investigational bioelectric signals targeting Klotho and follistatin pathways.

Klotho is one of the most widely studied proteins associated with healthy aging and has been investigated for its relationships with brain, kidney, cardiovascular, muscle and metabolic health. Follistatin is particularly important to muscle biology because of its relationship with myostatin signaling and muscle growth.

Lionheart is studying whether specialized BodStim protocols can increase or favorably influence Klotho, follistatin, muscle performance and other biomarkers associated with healthspan and longevity.
Klotho fight back

Lionheart Membership and Klotho-Up™ Protocol

Lionheart Longevity also offers a physician-guided annual membership program built around advanced diagnostics, personalized healthspan planning and access to Lionheart’s expanding regenerative-health ecosystem.

The membership includes comprehensive biomarker testing, physician-led review and a personalized protocol that may incorporate elements of the Lionheart Klotho-Up™ Protocol, depending on each member’s medical history, health goals, eligibility and physician recommendations.

The Klotho-Up™ Protocol is designed to bring together multiple healthspan strategies, including nutrition, supplementation, exercise, BodStim™ EMS, bioelectric stimulation, ongoing biomarker measurement and other physician-selected interventions. Advanced or investigational therapies are available only to eligible, consenting participants through appropriate clinical-study or medical-supervision pathways.
Klotho Levels
Health Optimization Membership
Klotho Protocol

Members also receive preferred or discounted pricing on eligible treatments, devices, diagnostics, supplements and other products, including products available through the Lionheart Longevity eStore Shop.

Learn more:

Expanding Network of Licensed Clinics

Lionheart is developing an expanding network of licensed clinics and treatment providers, including multiple locations serving communities throughout Orange County, California, as well as participating locations in other markets.

This network is intended to make Lionheart’s physician-guided programs, bioelectric technologies and regenerative-health protocols more accessible through a combination of in-clinic services, at-home programs and concierge support.

Eligible members may receive preferred pricing at participating licensed locations, subject to local availability, provider participation, medical appropriateness and applicable regulations.

View the growing network at Lionheart Longevity Locations.

Building a Multi-Modality Regenerative Medicine Platform

“Our vision is to move bioelectric medicine from individual stimulation applications toward an integrated system addressing multiple components of human aging,” said Howard J. Leonhardt, Executive Chairman and Co-CEO of Lionheart Health. “The Lionheart 240 gives us a commercial platform already being used by clinics. BodStim combines exercise with specialized bioelectric signaling, and our Octopus system being developed with the UCI Capstone Engineering Program represents our longer-term vision for multi-organ regeneration.”

Leonhardt added, “Our membership program and growing network of licensed clinics are helping translate our research and technologies into practical, physician-guided healthspan programs. Members can access personalized Klotho-Up™ strategies, preferred pricing on eligible treatments and products, and support through participating clinics—including multiple locations serving Orange County.”

“It is a tremendous honor to be recognized as a finalist among this group of 60 Orange County innovators,” Leonhardt continued. “This recognition belongs to our entire team of engineers, physicians, scientists, clinicians, manufacturing partners and research collaborators who have helped move these technologies forward.”
The ultimate development of the Lionheart Health team is a whole body regeneration system a “womb for adults”
Adaptive Womb

About Howard J. Leonhardt

Howard J. Leonhardt is a medical technology entrepreneur, inventor, founder of Leonhardt Ventures and Executive Chairman and Co-CEO of Lionheart Health, Inc. His work has focused on cardiovascular technologies, regenerative medicine, bioelectric stimulation, organ regeneration and technologies designed to improve healthy longevity.

About Lionheart Health, Inc.

Lionheart Health, Inc. is developing and commercializing a multi-modality healthspan and regenerative medicine platform combining programmable bioelectric stimulation, muscle stimulation, regenerative technologies, biological research and physician-guided longevity programs.

Its portfolio includes the Lionheart 240 Stimulator™, BodStim™ EMS platform, Klotho-Up™ Protocol and Octopus™ Multi-Organ Regeneration System, together with additional technologies under clinical, preclinical and engineering development.

Through its membership program, eStore and expanding network of licensed clinics—including multiple locations serving Orange County—Lionheart seeks to broaden responsible access to personalized healthspan diagnostics, products, treatments and research opportunities.

For additional company announcements and updates, visit the Lionheart Longevity News Page.

Forward-Looking Statement: This release contains forward-looking statements regarding technologies, products, services, membership benefits, clinic expansion and research programs under development. Investigational applications described in this release have not necessarily been established as safe or effective or cleared or approved by the U.S. Food and Drug Administration for the specific healthspan, longevity, Klotho, follistatin, regenerative or multi-organ applications described. Research objectives and preliminary findings should not be interpreted as established clinical outcomes. Products, treatments, discounts and services may vary by location, provider participation, eligibility and applicable regulations.
Howard J. Leonhardt
Executive Chairman & co-CEO
Lionheart Health, Inc.
Leonhardt Ventures LLC
R&D Lab 5270 California Ave, Irvine, CA 92617
 
Research Clinic & Training Center
CoreViva Ai Enhanced MRI